Colchicine for Diabetic Nephropathy Trial

Summary

Forty patients with diabetic nephropathy will be treated with colchicine up to 2 mg, or placebo, for 18 months. A follow up will be performed after 12 additional months. The primary outcome will be a significant reduction or stabilization of proteinuria during the 18 month treatment period.

Timeline

Start

2016-02-22

Primary completion

2019-04-30

Completion

2019-04-30

Drugs

Indications